Fig. 3From: The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in CanadaCost-effectiveness acceptability curve for as-needed budesonide-formoterol versus low-dose maintenance ICS plus as-needed SABA. Vertical line on graph indicates WTP threshold of $50,000. bid: twice daily; ICS: inhaled corticosteroid; SABA: short-acting β2-agonist; WTP: willingness-to-pay thresholdBack to article page